U.S. markets open in 4 hours 50 minutes
  • S&P Futures

    3,850.25
    +5.25 (+0.14%)
     
  • Dow Futures

    31,102.00
    +6.00 (+0.02%)
     
  • Nasdaq Futures

    13,349.50
    +55.25 (+0.42%)
     
  • Russell 2000 Futures

    2,156.10
    -1.60 (-0.07%)
     
  • Crude Oil

    52.88
    -0.43 (-0.81%)
     
  • Gold

    1,870.00
    +3.50 (+0.19%)
     
  • Silver

    25.96
    +0.19 (+0.75%)
     
  • EUR/USD

    1.2152
    +0.0037 (+0.30%)
     
  • 10-Yr Bond

    1.0900
    0.0000 (0.00%)
     
  • Vix

    21.48
    -1.76 (-7.57%)
     
  • GBP/USD

    1.3737
    +0.0081 (+0.60%)
     
  • USD/JPY

    103.4200
    -0.1500 (-0.14%)
     
  • BTC-USD

    32,694.95
    -807.15 (-2.41%)
     
  • CMC Crypto 200

    647.16
    -53.46 (-7.63%)
     
  • FTSE 100

    6,730.00
    -10.39 (-0.15%)
     
  • Nikkei 225

    28,756.86
    +233.60 (+0.82%)
     

U.S. FDA puts early-stage trial of Altimmune's COVID-19 vaccine on hold

·1 min read

Dec 23 (Reuters) - Altimmune Inc said on Wednesday the U.S. Food and Drug Administration had put a clinical hold on its application to begin human testing of its single-dose COVID-19 vaccine, AdCOVID.

The FDA sought additional data on the vaccine candidate's chemistry, manufacturing and controls, and asked the company for some protocol changes.

Altimmune said it has responded to the agency's letter received on Dec. 22.

The company said it does not see the FDA's hold to have a huge impact on the timeline of the overall clinical development of AdCOVID. (Reporting by Chavi Mehta in Bengaluru; Editing by Maju Samuel)